Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
6,775 total articles
Milestone Pharmaceuticals announced it will release its first quarter 2026 financial results and provide a business update before market open on May 13, 2026. The company will hold a conference call and webcast for investors to discuss the results and recent developments. Milestone is a biopharmaceutical company focusing on cardiovascular medicines…
Taysha Gene Therapies reported Q1 2026 financial results and provided an update on its TSHA-102 gene therapy development for Rett syndrome. The company reaffirmed FDA alignment on the Biologics License Application (BLA) pathway, including pivotal trial design and the potential to submit for approval based on a six-month interim analysis from the RE…
SteelPhalt, a business unit within Harsco Environmental's ecoproducts line, announced the launch of a verified Environmental Product Declaration (EPD) tool under the International EPD System. The tool provides transparent, lifecycle-based environmental impact data for its sustainable asphalt products, helping customers align with sustainability goa…
LGI Homes, a publicly traded homebuilder, has launched Cider Hill, a new townhome community in Winston-Salem, NC, featuring 36 homes with competitive pricing starting in the $350,000 range. The community offers modern, energy-efficient homes with appealing amenities in a prime suburban location, targeting buyers seeking a blend of convenience and l…
Aktis Oncology, a clinical-stage company specializing in targeted radiopharmaceutical therapies for cancer, announced that its CEO, Dr. Matthew Roden, will present at the upcoming BofA Securities Health Care Conference. The company focuses on a proprietary miniprotein radioconjugate platform designed to deliver radioisotopes precisely to tumors, wi…
IN8bio, a clinical-stage biopharmaceutical company, announced upcoming presentations detailing progress in its gamma-delta T cell engager platform and clinical therapies, including new data on glioblastoma treatment. The company will showcase its innovative pipeline at its May 21 R&D Day and at prominent conferences such as ASCO, ISCT, and ASGCT, h…
Annexon, Inc., a biopharmaceutical company developing targeted immunotherapies for neuroinflammatory diseases, announced that CEO Douglas Love will present at the upcoming Bank of America Securities Health Care Conference on May 13, 2026. The presentation will be webcast live and archived for investors.
VisionWave Holdings, Inc. announced strategic operational integration of its recently acquired xCalibre™ AI video intelligence platform into Solar Drone's autonomous long-endurance flight platforms. This initiative aims to create the Persistent Digital Sentinel™, an AI-driven, cloud-independent aerial defense system capable of continuous real-time …
ChronoScale Corporation announces the appointment of Cenly Chen as Chief Executive Officer and board member. Chen brings over 20 years of experience in enterprise infrastructure and high-performance computing, including leadership roles at Super Micro Computer, Inc. This leadership change aims to position ChronoScale to scale capacity, meet rising …
Navigator Holdings Ltd. announced preliminary unaudited financial results for Q1 2026. The company reported a net income increase to $35.5 million, driven by improved operational performance and fleet management, despite a slight decline in operating revenues. Navigator declared a $0.07 per share dividend and plans share repurchases equal to 30% of…
Treasure Global Inc., a Malaysian technology company listed on NASDAQ, announced the appointment of Tengku Dato’ Musahiddin Shah to its Board of Directors as an Independent Director. His extensive experience in government and private sector engagements is expected to enhance the company's governance and strategic positioning, particularly regarding…
ASP Isotopes Inc., a US-listed company, announces that its wholly-owned subsidiary Quantum Leap Energy (QLE) has appointed Dr. Peter S. Fiske to its Strategic Advisory Board. Dr. Fiske brings extensive experience in technology commercialization, government relations, and strategic partnerships, which is expected to bolster QLE's position in advanci…
Holley Performance Brands reported its first quarter 2026 financial results, highlighting net income growth to $7.3 million and adjusted EBITDA margin expansion to 18.5%. Despite a slight decline in net sales due to portfolio optimization efforts, the company executed cost-saving initiatives, improved cash flow, and completed the acquisition of HRX…
Altimmune, a late clinical-stage biopharmaceutical company focused on therapies for serious liver diseases, will report its first quarter 2026 financial results on May 13, 2026. Management will host a conference call providing financial details and a business update the same day.
Crescent Biopharma, a clinical-stage biotechnology company specializing in oncology therapies, will present at several investor conferences throughout May 2026, including BofA Securities Healthcare Conference, Stifel Virtual Targeted Oncology Forum, and TD Cowen Oncology Innovation Summit. The events feature virtual and in-person fireside chats foc…
Medline Inc. announced first quarter 2026 results showing strong net sales growth of 10.7% to $7.4 billion driven by new customer signings and organic growth, while net income declined 25.8% to $239 million due to increased costs and expenses including tariffs and IPO-related employee bonuses. The company raised its full year 2026 organic sales gro…
Applied Materials, Inc. announced that its senior management team will participate in several upcoming investor conferences, including J.P. Morgan, Bernstein, and BofA Securities events. The company will webcast their sessions, providing updates on their materials engineering solutions critical to semiconductor and advanced display industries. The …
Since its Nasdaq listing in early 2026, VenHub Global, Inc. has accelerated growth by expanding its Las Vegas production capacity, advancing autonomous retail technology, securing multiple new Smart Store deployment agreements, and strengthening its payments platform. The company aims to transform high-traffic venues across key sectors by offering …
Bioventus Inc. reported solid financial results for Q1 2026, with revenue increasing 7% to $132.1 million driven by growth across its Pain Treatments, Surgical Solutions, and Restorative Therapies segments. GAAP earnings improved to $0.04 per diluted share from a prior year loss, and non-GAAP earnings nearly doubled to $0.15 per diluted share. The …
BriaCell Therapeutics has received FDA clearance to initiate clinical trials for Bria-BRES+, its next-generation personalized immunotherapy targeting metastatic breast cancer. Building on promising results from the earlier Bria-OTS program, the new therapy aims to enhance immune activation and offer improved efficacy. The company plans to start the…
Cronos Group Inc., a global cannabis company, announced the expanded availability of its Spinach STIX®, a cylindrical-style pre-roll, across multiple Canadian provinces. This expansion targets the rising consumer demand for innovative and portable cannabis pre-roll formats in the Canadian market, which accounts for over a third of national retail c…
Dragonfly Energy Holdings Corp. has been awarded a second round of funding from the Nevada Tech Hub, amounting to $527,000, to expand its in-house cylindrical lithium battery cell prototyping and advanced testing capabilities. This investment aims to accelerate research and development, enhance validation processes, and strengthen integration betwe…
StepStone Group Inc., a global private markets investment firm, announced it will release its financial results for the fourth quarter and fiscal year ended March 31, 2026, on May 20, 2026, followed by a webcast and conference call to discuss the results.
Kura Oncology, a biopharmaceutical company focused on precision cancer medicines, announced its participation in the Bank of America Securities 2026 Healthcare Conference, featuring a fireside chat with company management where they will discuss their pipeline and recent FDA-approved drug KOMZIFTI™ for acute myeloid leukemia.
BridgeBio Pharma announced that the Brazilian regulatory agency ANVISA has approved acoramidis, marketed as Beyonttra, for treatment of transthyretin amyloidosis cardiomyopathy (ATTR-CM). This approval follows positive Phase 3 trial results demonstrating significant reductions in cardiovascular events and hospitalizations, marking the first near-co…
